The efficacy of the BCG vaccine against newly emerging clinical strains of mycobacterium tuberculosis

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Henao Tamayo, Marcela ^a   Shanley, Crystal A ^a   Verma, Deepshikha ^a   Zilavy, Andrew ^a   Stapleton, Margaret C ^a   Furney, Synthia K ^a   Podell, Brendan ^a   Orme, Ian M ^a  

^a Department of Ecosystem Science and Sustainability   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AERAS 422 VACCINE; BACTERIAL VACCINE; BCG VACCINE; UNCLASSIFIED DRUG; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; FLOW CYTOMETRY; HARTLEY GUINEA PIG; HISTOPATHOLOGY; LUNG PARENCHYMA; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTECTION; SOUTH AFRICA; TUBERCULOSIS; UNITED STATES; ANIMAL; C57BL MOUSE; GUINEA PIG; IMMUNOLOGY;

ANIMALS; BCG VACCINE; FEMALE; GUINEA PIGS; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; VACCINE POTENCY;

EID: 84947474870     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136500     Document Type: Article

References (28)

1. World Health Organization G (2014) Global tuberculosis report. Available: http://www.who.int/tb/publications/global-report/en/.
2. Falzon D, Weyer K, Raviglione MC (2013) Drug-resistant tuberculosis: latest advances. Lancet Respir Med 1: e9-e10. doi: 10.1016/S2213-2600(12)70056-5 PMID: 24321818
3. Walker NF, Meintjes G, Wilkinson RJ (2013) HIV-1 and the immune response to TB. Future Virol 8: 57-80. PMID: 23653664
4. Martinez N, Kornfeld H (2014) Diabetes and immunity to tuberculosis. Eur J Immunol 44: 617-626. doi: 10.1002/eji.201344301 PMID: 24448841
5. Podell BK, Ackart DF, Obregon-Henao A, Eck SP, Henao-Tamayo M, Richardson M, et al. (2014) Increased severity of tuberculosis in Guinea pigs with type 2 diabetes: a model of diabetes-tuberculosis comorbidity. Am J Pathol 184: 1104-1118. doi: 10.1016/j.ajpath.2013.12.015 PMID: 24492198
6. Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S, et al. (2013) Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 381: 1021-1028. PMID: 23391465
7. McShane H, Williams A (2014) A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data. Tuberculosis (Edinb) 94: 105-110.
8. Ordway D, Henao-Tamayo M, Harton M, Palanisamy G, Troudt J, Shanley C, et al. (2007) The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. J Immunol 179: 522-531. PMID: 17579073
9. Ordway DJ, Shang S, Henao-Tamayo M, Obregon-Henao A, Nold L, Caraway M, et al. (2011) Mycobacterium bovis BCG-mediated protection against W-Beijing strains of Mycobacterium tuberculosis is diminished concomitant with the emergence of regulatory T cells. Clin Vaccine Immunol 18: 1527-1535. doi: 10.1128/CVI.05127-11 PMID: 21795460
10. Palanisamy GS, DuTeau N, Eisenach KD, Cave DM, Theus SA, Kreiswirth BN, et al. (2009) Clinical strains of Mycobacterium tuberculosis display a wide range of virulence in guinea pigs. Tuberculosis (Edinb) 89: 203-209.
11. Kupferschmidt K (2011) Infectious disease. Taking a new shot at a TB vaccine. Science 334: 1488-1490. doi: 10.1126/science.334.6062.1488 PMID: 22174226
12. Shanley CA, Streicher EM, Warren RM, Victor TC, Orme IM (2013) Characterization of W-Beijing isolates of Mycobacterium tuberculosis from the Western Cape. Vaccine 31: 5934-5939. doi: 10.1016/j. vaccine.2013.10.044 PMID: 24144471
13. Jeon BY, Derrick SC, Lim J, Kolibab K, Dheenadhayalan V, Yang AL, et al. (2008) Mycobacterium bovis BCG immunization induces protective immunity against nine different Mycobacterium tuberculosis strains in mice. Infect Immun 76: 5173-5180. doi: 10.1128/IAI.00019-08 PMID: 18710860
14. Shang S, Harton M, Tamayo MH, Shanley C, Palanisamy GS, Caraway M, et al. (2011) Increased Foxp3 expression in guinea pigs infected with W-Beijing strains of M. tuberculosis. Tuberculosis (Edinb) 91: 378-385.
15. Orme I (2014) Letter to the editor. Tuberculosis (Edinb) 94: 717.
16. Kato-Maeda M, Shanley CA, Ackart D, Jarlsberg LG, Shang S, Obregon-Henao A, et al. (2012) Beijing sublineages of Mycobacterium tuberculosis differ in pathogenicity in the guinea pig. Clin Vaccine Immunol 19: 1227-1237. doi: 10.1128/CVI.00250-12 PMID: 22718126
17. Johnson LF, Rehle TM, Jooste S, Bekker LG (2015) Rates of HIV testing and diagnosis in South Africa: successes and challenges. AIDS 29: 1401-1409. doi: 10.1097/QAD.0000000000000721 PMID: 26091299
18. Karim QA, Kharsany AB, Frohlich JA, Werner L, Mashego M, Mlotshwa M, et al. (2011) Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in Kwa Zulu-Natal, South Africa. Int J Epidemiol 40: 922-930. doi: 10.1093/ije/dyq176 PMID: 21047913
19. Ramirez-Avila L, Regan S, Chetty S, Giddy J, Ross D, Katz JN, et al. (2014) HIV testing rates, prevalence, and knowledge among outpatients in Durban, South Africa: Time trends over four years. Int J STD AIDS 26(10): 704-709. doi: 10.1177/0956462414551234 PMID: 25228664
20. Goonetilleke NP, McShane H, Hannan CM, Anderson RJ, Brookes RH, Hill AV (2003) Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J Immunol 171: 1602-1609. PMID: 12874255
21. Sharpe SA, McShane H, Dennis MJ, Basaraba RJ, Gleeson F, Hall G, et al. (2010) Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing. Clin Vaccine Immunol 17: 1170-1182. doi: 10.1128/CVI.00079-10 PMID: 20534795
22. Verreck FA, Vervenne RA, Kondova I, van Kralingen KW, Remarque EJ, Braskamp G, et al. (2009) MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques. PLOS ONE 4: e5264. doi: 10.1371/journal. pone.0005264 PMID: 19367339
23. Williams A, Goonetilleke NP, McShane H, Clark SO, Hatch G, Gilbert SC, et al. (2005) Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs. Infect Immun 73: 3814-3816. PMID: 15908420
24. Andersen P, Kaufmann SH (2014) Novel vaccination strategies against tuberculosis. Cold Spring Harb Perspect Med 4. doi: 10.1101/cshperspect.a018523
25. Brennan MJ, Stone MR, Evans T (2012) A rational vaccine pipeline for tuberculosis. Int J Tuberc Lung Dis 16: 1566-1573. doi: 10.5588/ijtld.12.0569 PMID: 23131253
26. Orme IM (2011) Development of new vaccines and drugs for TB: limitations and potential strategic errors. Future Microbiol 6: 161-177. doi: 10.2217/fmb.10.168 PMID: 21366417
27. Orme IM (2013) Vaccine development for tuberculosis: current progress. Drugs 73: 1015-1024. doi: 10.1007/s40265-013-0081-8 PMID: 23794129
28. Grode L, Seiler P, Baumann S, Hess J, Brinkmann V, Nasser Addine A, et al. (2005) Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin. J Clin Invest 115: 2472-2479. PMID: 16110326